Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The US is the priciest market for acetylsalicylic acid, and 2025 only stretched that lead. Prices there firmed from USD 2.70/KG in Q1 to USD 2.887/KG by Q4, up 6.9%, as new duties on imported actives lifted domestic pricing. The global average rose alongside, from USD 2.46/KG to USD 2.57/KG, a 4.5% gain. The climb carried into 2026. Winter demand and tighter Chinese supply pushed the global average to about USD 2.64/KG in Q1 and USD 2.67/KG in Q2. We expect a global band of USD 2.62 to 2.80/KG through H2 2026.
Acetylsalicylic acid, the aspirin everyone knows, is the acetate ester of salicylic acid. Producers acetylate salicylic acid with acetic anhydride over an acid catalyst, then crystallise and dry it to a white powder. Salicylic acid itself comes from phenol via the Kolbe-Schmitt reaction, so the cost chain runs phenol to salicylic acid to aspirin, with acetic anhydride the second key input. It trades as pharmaceutical-grade active to USP, EP, and BP standards, plus technical grades. Demand splits three ways: over-the-counter painkillers and fever reducers, a big and growing low-dose antiplatelet segment for heart-disease prevention, and rising interest in long-term cancer prevention. China and India hold most of the active-ingredient capacity. Salicylic acid and acetic anhydride costs, cardiovascular and OTC demand, and trade policy set the price. Pharmaceutical grade runs to tight impurity limits on free salicylic acid and heavy metals, and GMP compliance is as much a cost driver as the chemistry. Capacity is concentrated in China and India, so audit cycles and export policy in those two countries move the global balance more than demand does.
The balance leans firm into H2 2026. OTC and cardiovascular demand held offtake steady, and periodic Chinese environmental audits kept spot supply in check. Salicylic acid and acetic anhydride costs stayed high enough to support the production floor.
Demand here is defensive. OTC painkiller use is steady, and the low-dose cardiovascular segment keeps growing with ageing populations, which gives the market a floor that holds through the cycle. Winter sharpens the first-quarter peak in the northern hemisphere. The volatility lives on the supply side, where Chinese and Indian plants set global availability and the odd environmental audit pulls spot volume out with no notice. Trade policy stacks on top, since duties on imported actives redraw the regional gaps directly. An ageing population in the major markets keeps the low-dose cardiovascular segment growing regardless of the economic cycle.
It's a two-sided outlook. On the push side, any fresh salicylic acid or acetic anhydride cost rise, or a deeper round of Chinese audit cuts, lifts offers past the top of the range. On the pull side, softer OTC demand after winter or idled Chinese capacity coming back would ease the average down.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 2.62 - 2.80 | Winter demand and firm feedstock cost support |
| United States | 2.92 - 3.10 | Import duties keep the US the dearest market |
| China | 2.55 - 2.72 | Large API capacity keeps China cheapest |
| Germany | 2.42 - 2.58 | Import CFR costs and freight hold the level |
| India | 2.90 - 3.05 | Import actives and price regulation firm buying |
Top of the table again. The US held USD 2.98/KG, up about 1.0%, with import duties and steady cardiovascular demand keeping it at a premium. Buyers sourcing to USP standard paid up for reliable supply, and the duty structure on imported actives left little cheaper alternative.
Why did the price of Acetylsalicylic Acid change in Q2 2026 in the United States?
Duties held domestic prices up and cardiovascular and OTC demand stayed steady, so the US sat at USD 2.98/KG.
Firmer export inquiries from Europe and Southeast Asia and audit-trimmed capacity lifted China about 1.1% to USD 2.59/KG. It stayed the lowest on deep domestic output, though producers navigating periodic environmental checks watched available spot volume more closely than in prior quarters.
Why did the price of Acetylsalicylic Acid change in Q2 2026 in China?
Export pull firmed offers and environmental audits thinned spot supply. Even so, China's capacity kept it lowest at USD 2.59/KG.
Germany, drawing most of its supply from Asia, came in at USD 2.45/KG after a 1.2% rise. It followed firmer Chinese and Indian offers plus freight, with pharmaceutical buyers holding steady term cover and little local production to cushion the delivered cost.
Why did the price of Acetylsalicylic Acid change in Q2 2026 in Germany?
German pricing tracks Asian offers. Firmer Chinese and Indian material plus freight lifted CFR to USD 2.45/KG.
Just behind the US: India at USD 2.95/KG, up roughly 1.0%. Costlier imported feedstock met steady essential-medicine demand under domestic price control, and manufacturers balanced regulated ceilings against rising salicylic acid and acetic anhydride costs.
Why did the price of Acetylsalicylic Acid change in Q2 2026 in India?
Costlier imported feedstock met steady essential-medicine demand, and under regulated pricing India settled at USD 2.95/KG.
Higher into the new year: the US averaged USD 2.95/KG, up about 2.2% from USD 2.887/KG. Import duties held the baseline elevated, and a seasonal winter lift in over-the-counter analgesic demand added pull just as supply stayed tight.
Why did the price of Acetylsalicylic Acid change in Q1 2026 in the United States?
Duties kept prices high and winter OTC demand added pull, taking the US to USD 2.95/KG.
The steepest gain of the four. China rose to USD 2.563/KG, about 3.0% off USD 2.488/KG, as audits thinned availability just as export demand firmed. Producers with clean compliance records commanded firmer offers, and spot material grew scarce through the quarter.
Why did the price of Acetylsalicylic Acid change in Q1 2026 in China?
Audits tightened supply and export demand firmed at the same time, pushing China to USD 2.563/KG.
Firmer Asian export offers into the region lifted Germany about 2.7% to USD 2.42/KG from USD 2.356/KG. The rise was almost entirely imported-cost driven, with local demand from OTC and cardiovascular formulations holding steady more than surging.
Why did the price of Acetylsalicylic Acid change in Q1 2026 in Germany?
Firmer Asian offers plus freight lifted German CFR to USD 2.42/KG.
India, moving from USD 2.863/KG to USD 2.92/KG on a roughly 2.0% rise, felt rising imported feedstock and manufacturing costs under regulated pricing. Producers passed through what the price ceilings allowed, keeping India close behind the US.
Why did the price of Acetylsalicylic Acid change in Q1 2026 in India?
Costlier imported feedstock, capped by regulated pricing, moved India to USD 2.92/KG.
Acetylsalicylic acid rose through 2025 and kept climbing into 2026, an unusually steady uptrend built on trade policy and feedstock costs. The average worked up from USD 2.49/KG in Q2 2025 through USD 2.53/KG, USD 2.57/KG, USD 2.64/KG, and USD 2.67/KG. That's a net 7.2% gain across the window. US duties, Chinese audit-driven supply trims, and firmer feedstock all pushed the same way.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 2.67 | +1.1% | ↑ Rising |
| Q1 2026 | 2.64 | +2.7% | ↑ Rising |
| Q4 2025 | 2.57 | +1.6% | ↑ Rising |
| Q3 2025 | 2.53 | +1.6% | ↑ Rising |
| Q2 2025 | 2.49 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
The regional gaps widened on trade policy. In Q2 2026 the US at USD 2.98/KG and India at USD 2.95/KG formed a high cluster, both lifted by import costs, while China at USD 2.59/KG and Germany at USD 2.45/KG anchored the low end. The US-to-China gap near USD 0.39/KG is basically the duty structure in one number. As long as duties hold, that gap stays wide. Germany sits at the bottom despite being a high-cost economy, a reminder that for imported actives the landed Asian offer sets the level, not local costs.
2025 was a steady climb. The global average opened near USD 2.46/KG in Q1 and reached USD 2.57/KG by Q4, a 4.5% gain. New US duties on imported actives, periodic Chinese audits, and firm salicylic acid and acetic anhydride costs pushed it up quarter after quarter. By year-end the US and India had pulled clear of the Asian-supplied low tier, a gap trade policy widened as the year went on.
New duties on imported actives and steady OTC and cardiovascular demand firmed the US from about USD 2.70/KG to USD 2.887/KG, up 6.9% and dearest of the four. The trade measures reset the domestic baseline early and held it there, with defensive pharmaceutical demand giving prices a firm floor.
Up but still cheapest: China rose from roughly USD 2.40/KG to USD 2.488/KG, about 3.7%. Audit-driven capacity trims and firmer export demand supported the climb, though deep active-ingredient capacity kept the country at the bottom of the range.
A milder climb. Germany firmed from about USD 2.28/KG to USD 2.356/KG, up 3.3%, tracking Asian export offers and freight. With supply almost entirely imported, the delivered Chinese and Indian cost set the pace all year.
India, lifted from about USD 2.72/KG to USD 2.863/KG on a 5.3% gain, felt costlier imported feedstock and manufacturing under regulated essential-medicine pricing. Strong domestic and export demand for finished aspirin kept the active in steady call throughout.
Expert Market Research: Your Source for Real-Time Acetylsalicylic Acid Price Intelligence
We track acetylsalicylic acid prices continuously across every major producing and consuming region. Our analysts follow the chain from phenol, salicylic acid, and acetic anhydride through OTC, cardiovascular, and hospital demand to trade policy and regional import parity, so you see the reason behind every move. Contact Expert Market Research today for acetylsalicylic acid pricing data, tailored analysis, and procurement advisory shaped around your sourcing strategy.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
It's the active ingredient in aspirin. It works as an over-the-counter painkiller and fever reducer, a low-dose antiplatelet for cardiovascular prevention, and, more and more, in long-term cancer-prevention research and use. The low-dose cardiovascular use has become the structural growth driver, ahead of ordinary painkiller demand.
In Q2 2026 it averaged USD 2.98/KG in the US, USD 2.59/KG in China, USD 2.45/KG in Germany, and USD 2.95/KG in India. The US is dearest on import duties, China cheapest on deep API capacity.
Up, steadily. The global average climbed from USD 2.46/KG in Q1 2025 to USD 2.57/KG by Q4, a 4.5% gain, on trade policy and firm feedstock costs.
New US duties on imported actives, periodic Chinese audits that trimmed supply, and firmer salicylic acid and acetic anhydride costs all pushed prices up together.
We expect a global average of USD 2.62 to 2.80/KG through H2 2026, helped by winter and cardiovascular demand and firm feedstock costs. A fresh round of Chinese audits or another duty change could push the average past the top of that band.
The US runs dearest on import duties, India firm on imported actives and price regulation, Germany tracks Asian offers plus freight, and China prices lowest on its large API capacity.
We update this report monthly. For real-time pricing, reach the Expert Market Research team directly.
Salicylic acid and acetic anhydride costs are the main levers, with phenol behind them. OTC and cardiovascular demand set the pull, and Chinese audit cycles and trade policy drive the sharper regional moves. Chinese environmental audits are the classic trigger for a sudden squeeze, since they remove spot volume with little notice.
China holds the most active-ingredient capacity, then India, with some output in Europe. Shift salicylic acid costs or Chinese supply and it ripples through every market. Between them, China and India set the floor that every other region imports against.
The quarterly trend and forward band help you time contracts and set cover. Track salicylic acid and acetic anhydride as lead signals and watch Chinese audit cycles for an early warning. Keep an eye on duty schedules too, since they reshape the US and India premiums and change the case for regional versus imported sourcing. For a regulated essential medicine, locking multi-quarter cover protects against the audit-driven spikes that hit spot hardest.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.